Publications by authors named "P Cioli"

Claim this Profile
P
Pharmacokinetic and Pharmacodynamic Head-to-Head Comparison of Clinical, Equivalent Doses of Insulin Glargine 300 units · mL and Insulin Degludec 100 units · mL in Type 1 Diabetes.
Paola Lucidi, Paola Candeloro, Patrizia Cioli, Anna Marinelli Andreoli, Chiara Pascucci

Diabetes Care· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus.
Paola Lucidi, Francesca Porcellati, Patrizia Cioli, Paola Candeloro, Anna Marinelli Andreoli

Diabetes Technol Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes.
Francesca Porcellati, Paola Lucidi, Paola Candeloro, Patrizia Cioli, Anna Marinelli Andreoli

Diabetes Care· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes.
P Lucidi, F Porcellati, A Marinelli Andreoli, P Candeloro, P Cioli

Diabetes Metab· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection.
Paola Lucidi, Francesca Porcellati, Anna Marinelli Andreoli, Ilaria Carriero, Paola Candeloro, Patrizia Cioli

Diabetes Care· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis